|
SOUTHAMPTON, Pa., Jan. 5 /PRNewswire-FirstCall/ -- Environmental Tectonics
Corporation (Amex: ETC) ("ETC" or the "Company") announced today that it had
signed a two-year delivery contract, valued at nearly one million US dollars,
with Koike Medical Co., Ltd., ETC's hyperbaric BARA-MED(R) monoplace chamber
distributor in Japan.
All chambers will be computer-controlled and will include ETC's patient- friendly Smooth-Ride(TM) compression protocol. The chambers will also be outfitted with standard connectors to ensure compatibility with Radiometer and Perimed transcutaneous oxygen monitors, and with Koike Medical's BARAMO, a hyperbaric-compatible critical care monitor that includes ECG, temperature, respiration, pulse / heart rate, and non-invasive blood pressure. Russell E. Peterson, Ph.D., Director of the BioMedical Systems Group, stated, "The Japanese hyperbaric chamber market is one of the largest in the world and is very important to us. We are pleased that Koike Medical is continuing to expand their presence in this competitive market and are projecting significantly more sales of the BARA-MED(R) monoplace in the coming year." Currently, both in the United States and overseas, only a small percentage of hospitals offer hyperbaric oxygen therapy (HBO). The number of chambers is increasing, however, as the benefits of hyperbaric medicine become more widely recognized by mainstream medicine. ETC's BioMedical Systems Group and our customers remain at the forefront of hyperbaric medicine, in equipment, research, and application. In addition to their regular use in clinical treatments at some of the best medical facilities around the world, ETC hyperbaric chambers are routinely involved in research on new indications for which HBO holds promise, and on the refinement of treatment protocols for established indications. ETC designs, develops, installs and maintains aircrew training systems, public entertainment systems, process simulation systems (sterilization and environmental), clinical hyperbaric systems, environmental testing and simulation systems, and related products for domestic and international customers. This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934. We have based these forward- looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about the Company that may cause our actual results, levels of activity, performance or achievements to be materially different from any other future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "continue," or the negative of such terms or similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, contract cancellations, failure to obtain new contracts, political unrest in customer countries, unfavorable results in litigation, general economic conditions, and those issues identified from time to time in our Securities and Exchange Commission filings and other public documents, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended February 27, 2004. |
www.etcbiomedical.com